A 44-year-old male presented with severe obstructive sleep apnoea (OSA) which persisted despite septoplasty, inferior turbinectomy, uvulopalatopharyngoplasty and tonsillectomy. He underwent a diagnostic drug-induced sleep endoscopy which showed his tongue base as another source of obstruction. This was followed by the first transoral robotic surgery (TORS) of the tongue base performed in our centre. We discuss the novel use of dexmedetomidine for drug-induced sleep endoscopy and the anaesthetic management of this challenging group of patients undergoing this new surgical procedure.
INTRODUCTION
Obstructive Sleep Apnoea (OSA) can result in significant daytime somnolence, with implications on safety and quality of life. There is also an increased risk of various cardio-respiratory disorders. The treatment options for OSA are lifestyle modifications to address risk factors such as obesity 1 , instituting continuous positive airway pressure therapy 2 , use of dental devices 3 and surgery. Surgical intervention is indicated only if the patient's general condition allows surgery and a rectifiable pathoanatomical finding has been carefully diagnostically evaluated before the operation.
Drug-induced sleep endoscopy is used to determine the individual's pattern of airway obstruction 4 and guide surgical treatment. Sleep is induced pharmacologically and a small and flexible nasoscope is introduced nasally. The possible sites of obstruction in the upper airway is then observed. The possible sites of collapse are the palatal region, tonsils, tongue base, epiglottis, hypopharynx and lateral pharyngeal walls. Areas of obstruction may be in isolation or there may be multiple levels of obstruction.
We describe a case of a patient who underwent transoral robotic resection of the tongue base following dexmedetomidine-induced sleep endoscopy.
CASE HISTORY
The patient was a 44-year-old Chinese male who had a history of persistent OSA. He previously had septoplasty and inferior turbinoplasty, followed by an uvulopalatopharyngoplasty (UPPP) and tonsillectomy nine years later and septoplasty and inferior turbinectomy the following year. Sleep study done four months later showed an apnoeahypopnoea index (AHI) of 16.6. Significantly, during rapid eye movement (REM) sleep, AHI was 48.9 versus non-REM AHI of 15.0. His other comorbidities included hypertension and hyperlipidaemia. His weight was 77kg, height was 165 cm with a body mass index (BMI) of 28.3.
The patient had consented to drug-induced sleep endoscopy, followed by transoral robotic resection of the tongue base. A large bore 18 Gauge intravenous (IV) cannula was inserted in the left forearm for the administration of medications to induce sedation and anaesthesia. Standard anaesthetic Proceedings of Singapore Healthcare  Volume 22  Number 2  2013 monitoring was applied with the addition of the Bispectral Index (BIS®) brain monitoring.
His nasal passages and pharynx were topicalised with co-phenylcaine (Lignocaine 5%, Phenylephrine 0.5%) spray, three sprays to each nostril. Oxygen supplementation via nasal cannula at 2 litres per minute (l/min) was given during sleep endoscopy. Intravenous glycopyrrolate 0.2mg was given to reduce oropharyngeal secretions. To simulate sleep conditions, IV dexmedetomidine was used for sedation, aiming for a BIS reading of 70-80 for light sedation, followed by BIS reading of 60-70 for deep sleep. A loading dose of dexmedetomidine of 1 mcg/kg was given over seven minutes, followed by a 1mcg/kg/hr infusion rate for maintenance. Sleep endoscopy lasted for approximately 15 minutes, during which time the lowest BIS recorded whilst on dexmedetomidine sedation was 75. The patient maintained a Ramsay sedation score of at least three throughout the procedure and tolerated the nasal endoscopy. Vital signs remained stable, with oxygen saturations at 100% throughout the sleep endoscopy. Initial blood pressure was 152/98 mm Hg. The lowest blood pressure reading recorded was 115/75 mm Hg. There was a slight decline of heart rate from a starting value of 75 to 65 beats per minute by the end of the sleep endoscopy. A total of 85.6 mcg of dexmedetomidine was used for this procedure which lasted 15 minutes. This procedure confirmed that the tongue base was causing obstruction during sleep.
The second procedure, transoral robotic resection of tongue base, required general anaesthesia. General anaesthesia was induced uneventfully with IV propofol 80mg while continuing a background infusion of dexmedetomidine. Mask ventilation was easy and the patient was then paralysed with IV bolus of 50mg of atracurium. Laryngoscopy revealed a Grade IIa larynx. A size 7.5 armoured endotrachael tube (ETT) was inserted nasally and anchored to the left of the patient. Anaesthesia was maintained with desflurane in an oxygen and air mixture. Two pieces of sponge was inserted between the ETT and nares to prevent pressure necrosis. His eyes were covered with tape and protected with gauze padding. Dexmedetomidine infusion was stopped when alveolar desflurane 1.0 MAC concentration was reached. Remifentanil infusion was commenced to obtund any noxious surgical stimuli. A dose of IV dexamethasone was given prior to incision.
The patient was positioned to facilitate the surgical procedure. All vulnerable pressure points were adequately padded and protected and intravenous lines were made accessible to the anaesthetists. The robot was positioned and surgery commenced as per routine. Surgery lasted for two hours, during which the patient maintained stable haemodynamics throughout. BIS values were appropriate for anaesthesia with a combination of desflurane in an oxygen-air mixture and IV remifentanil infusion. For analgesia, a total of 5mg of IV morphine was administered.
Postoperatively, the patient was kept sedated with IV dexmedetomidine 0.5 mcg/kg/hr while ventilated via the ETT. He was transferred to the Surgical Intensive Care Unit (SICU) at 1230h for gradual weaning off of the ventilator. The surgeon planned to extubate the patient the next day after airway assessment with a nasoscope. The patient was kept sedated with IV dexmedetomidine infusion of 0.2-0.6 mcg/kg/hr, targeting a Ramsay sedation score of 3. Nasoendoscopy was done on the first post-operation day (POD) which showed no airway swelling. The patient was extubated at 0950hrs and monitored in SICU for a few more hours before he was transferred to the High Dependency (HD) ward at 1500hrs. He was kept on oxygen supplementation until 0900h the following day. His overnight hourly saturation monitoring via pulse oximetry remained at 100%. Oxygen supplementation was stopped on the second POD at 0900h and he was transferred to the general ward. He was discharged on the third POD. No episodes of desaturation were noted during his entire ward stay. He was given oral paracetamol 1g, six-hourly and oral Etoricoxib 120mg once a day for analgesia. Patient was well on follow-up in the clinic.
DISCUSSION
This is the first TORS in our hospital for OSA. The use of dexmedetomidine in sedation for drug-induced sleep endoscopy has not been described in the literature.
Drug-Induced Sleep Endoscopy
Benzodiazepines 5 and propofol 6, 7 have been used solely or in combination 8 . For this patient, we used dexmedetomidine to induce sleep. Dexmedetomidine, a highly selective alpha 2 adrenergic agonist, has to be used with a controlled infusion device. It stimulates the alpha 2 -adrenergic Proceedings of Singapore Healthcare  Volume 22  Number 2  2013 receptors on the locus coeruleus in the brain stem. This increases the firing of the inhibitory neurons thereby reducing the central sympathetic output giving it sedative and anxiolytic properties. The analgesic effect of dexmedetomidine is produced by the action of the drug on the alpha 2 -adrenergic receptors on the dorsal horn of the spinal cord modulating the release of substance P. It is recommended that a loading dose of 1mcg/kg be given over 10 minutes followed by a range of dosages titrated to desired effect. Although dexmedetomidine does not have a direct effect on the heart, there may be a biphasic haemodynamic response with the initial loading dose. This transient increase in blood pressure and heart rate is then followed by a gradual decrease in heart rate and blood pressure. Transient hypertension has also been seen during the loading dose and this can be managed by reducing the rate or the total loading dose. The cardiovascular depression with hypotension and bradycardia can be treated with volume loading, atropine or ephedrine. No hypertension or hypotension was observed during loading infusion. The most significant change in blood pressure was a decrease to 115/75 mm Hg, approximately 25% below pre-induction blood pressure.
The target BIS level of 60-70, which should correspond to deep sedation, was not achieved. It suggests that BIS may not reliably predict the level of sedation 9 . Dexmedetomidine was selected as the sedative of choice for the procedure as it has been shown to cause much less respiratory depression than other sedatives 10 . This is a unique feature not observed with other sedatives used for similar trials, such as propofol, midazolam or remifentanil 11 . Most of the patients receiving dexmedetomidine as a sole agent experienced effective sedation, yet were readily aroused. This property makes it a particularly suitable drug for sleep studies. The analgesic effects and sympatholytic properties it possesses attenuate the response to the stimulation produced during nasal endoscopy, thus reducing the need for opioids 12 . As OSA is worsened with the use of opioids, it would certainly hamper the results of sleep studies.
Anaesthesia for Patients with OSA
Patients with OSA present the anaesthetist with challenges intra-operatively and post-operatively, which are largely related to airway management and the respiratory depressant effects of sedatives, anaesthetics and analgesics. In 2006, the American Society of Anesthesiologists (ASA) published a set of guidelines for the perioperative management of these patients 13 . The authors found that the literature lacked sufficient evidence-based findings and their recommendations were based largely on expert opinion.
Preoperative premedication with sedatives is avoided in these patients. They may have possible difficult airways, with potentially difficult mask ventilation and intubation. Difficulty with tracheal intubation occurs eight times more often in OSA patients than in non-OSA patients 14 . Regional anaesthesia should be used wherever feasible. However in our patient, general anaesthesia was indicated. The patient, equipment and personnel preparation should be made according to the ASA difficult airway management guidelines 15 .
In patients with OSA, there is a propensity for airway collapse, sleep deprivation and blunting of the physiological response to hypercarbia and hypoxia. This makes them sensitive to the respiratory depressant effects of anaesthetic agents, including sedatives, opioids and inhaled anaesthetics. Hence, short-acting agents (propofol, remifentanil, desflurane) should be used. Longer-acting drugs should be avoided as far as possible. Alpha-2 adrenergic agonist (clonidine, dexmedetomidine) may reduce intraoperative anaesthetic requirements and have an opioid sparing effect 16 . Tracheal extubation should be performed only after the OSA patient is fully conscious and the following verified: airway patency, adequate respiration and full reversal of neuromuscular blockade. The patient should preferably be extubated in a nonsupine (semi-upright or lateral) position 13 .
Postoperative management concerns include analgesia, oxygenation, patient positioning and monitoring. Postoperative desaturations were found to be more likely to occur in OSA patients receiving postoperative oral or parenteral opioids versus non-opioid analgesic agents 17 . A multimodal approach to analgesia should be adopted for their opioid sparing effect. These include infiltration of local anaesthetic by the surgeon intraoperatively, non-steroidal anti-inflammatory drugs, cyclooxygenase enzyme 2 inhibitors, paracetamol, tramadol, ketamine, pregabalin, gabapentin and/ or dexamethasone 18 . Supplemental oxygen should be administered in the postoperative period until Proceedings of Singapore Healthcare  Volume 22  Number 2  2013 they are able to maintain their baseline oxygen saturation on room air. If patients had been on continuous positive airway pressure prior to surgery, this should be instituted when they fall asleep postoperatively 13 . Patients should also be nursed in a non-supine (head up 30 degrees or lateral) position.
The intensity of monitoring and the length of time that postoperative patients with OSA should be monitored depends on the severity of OSA, the type of anaesthetic, the type of analgesia and the type of surgery that the patient has undergone. This patient had undergone surgery that had known complications of tongue base swelling and bleeding that could further compromise respiration postoperatively. Hence, he was kept intubated in SICU until his surgeons deemed him at minimal risk of these complications. Post-extubation, he continued to have bedside oximetry monitoring out of SICU until he was saturating well on room air.
Anaesthesia for TORS
TORS is a relatively new approach to resection of the tongue base 18 . Its advantages over traditional or laparoscopic surgery are improved dexterity and precision with 3-dimensional depth perception and fewer limitations. Robotic surgery itself also presents certain challenges to the anaesthetist.
Preoperatively, dental assessment was important not only for airway management, but also for surgical access. Due to the transoral route of surgery, a mouth gag was applied to facilitate placement of surgical instruments. Patients need to be counselled for dental damage, and a formal dental assessment is indicated if teeth appear suspect.
Intraoperatively, two main issues are managing space constraints and limited access to the patient. The DaVinci system consists of bulky equipment which takes up limited space in the operating theatre. The anaesthetist needs to find the optimal location for the anaesthetic delivery system, balancing the requirement of proximity to the patient versus the spatial requirements of the DaVinci system. Generally, anaesthetic delivery and monitoring systems are placed at the head end for most other robotic surgeries. In Otolaryngology patients, the anaesthetic delivery system is placed to the left of the patient at the level of the midtorso, tilted at a 45-60 degrees angle to cater for surgeons and components of the robotic system (refer fig. 1 ). The monitoring system is moved to the feet's end. The ETT should be well secured. As this is a shared airway, re-intubation is difficult during surgery if inadvertent extubation occurs. A steroid, like IV dexamethasone, can be given to minimise airway swelling in response to manipulation during surgery.
Due to the presence of multiple pieces of equipment, it is necessary to attach extensions to the IV cannula for IV access to the patient. Bony points have to be protected. There is potential for compressive injury from the robotic arms to the face. The eyes should be lubricated and padded. The robotic arms are monitored closely during surgery to prevent inadvertent pressure or crush injuries to the patient.
Operating theatre staff should be familiar with moving the robotic arms and detaching endoscopic instruments quickly to allow for quick access to the patient should resuscitation become necessary, as robotic arms are fixed implements positioned over the patient's chest 19 . Detachment speeds of within 30 seconds with repeated drills and familiarity with the equipment have been achieved 20 .
CONCLUSION
Patients with OSA coming for Otolaryngology procedures present to the anaesthetist numerous challenges and dangers. As the use of robotic surgery expands in the field of Otolaryngology, good communication and close cooperation between the anaesthetist and the surgeon is imperative in ensuring a safe and successful procedure.
